We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UE icon
726
Urban Edge Properties
UE
$2.9B
$971K ﹤0.01%
+45,401
New +$913K
DELL icon
727
Dell
DELL
$239B
$965K ﹤0.01%
8,143
-2,188
-21% -$255K
COOP
728
DELISTED
Mr. Cooper
COOP
$961K ﹤0.01%
10,424
+96
+0.9% +$8.51K
RBC icon
729
RBC Bearings
RBC
$17.4B
$960K ﹤0.01%
3,205
-188
-6% -$54.1K
DRS icon
730
Leonardo DRS
DRS
$12.4B
$958K ﹤0.01%
33,960
+435
+1% +$11.9K
AMCR icon
731
Amcor
AMCR
$21.2B
$954K ﹤0.01%
16,833
+10,190
+153% +$541K
BR icon
732
Broadridge
BR
$18.4B
$950K ﹤0.01%
4,419
+143
+3% +$29.9K
EQT icon
733
EQT Corp
EQT
$32.9B
$948K ﹤0.01%
25,862
+17,550
+211% +$597K
ANSS
734
DELISTED
Ansys
ANSS
$947K ﹤0.01%
2,973
+61
+2% +$19.4K
IDXX icon
735
Idexx Laboratories
IDXX
$44.9B
$947K ﹤0.01%
1,874
+48
+3% +$23.3K
RL icon
736
Ralph Lauren
RL
$22.4B
$945K ﹤0.01%
4,874
-531
-10% -$91.9K
TXO icon
737
TXO Partners LP
TXO
$724M
$943K ﹤0.01%
47,678
+5,831
+14% +$116K
CFG icon
738
Citizens Financial Group
CFG
$30.1B
$942K ﹤0.01%
22,947
-226
-1% -$9.13K
ESI icon
739
Element Solutions
ESI
$8.48B
$938K ﹤0.01%
34,523
-1,038
-3% -$27.2K
KNF icon
740
Knife River
KNF
$4.33B
$932K ﹤0.01%
10,429
+2,293
+28% +$179K
TEAM icon
741
Atlassian
TEAM
$26.5B
$931K ﹤0.01%
5,861
-5,350
-48% -$880K
IDA icon
742
Idacorp
IDA
$8B
$930K ﹤0.01%
9,023
+1,799
+25% +$180K
GTES icon
743
Gates Industrial Corporation Ltd.
GTES
$6.31B
$930K ﹤0.01%
53,001
+8,049
+18% +$137K
GGG icon
744
Graco
GGG
$13.2B
$924K ﹤0.01%
10,561
+543
+5% +$44.5K
TM icon
745
Toyota
TM
$228B
$924K ﹤0.01%
5,175
-214
-4% -$40K
SKYW icon
746
Skywest
SKYW
$4.35B
$921K ﹤0.01%
10,835
+98
+0.9% +$7.69K
FTV icon
747
Fortive
FTV
$18.2B
$918K ﹤0.01%
15,429
+1,716
+13% +$94.4K
RGEN icon
748
Repligen
RGEN
$6.91B
$916K ﹤0.01%
6,158
+728
+13% +$104K
VGK icon
749
Vanguard FTSE Europe ETF
VGK
$30.1B
$909K ﹤0.01%
12,785
-1,630
-11% -$112K
FOR icon
750
Forestar Group
FOR
$1.48B
$903K ﹤0.01%
27,886
+6,553
+31% +$204K
28 29
30
31 32

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.